Seroatlas · Human Serome Atlas

IGFBP7

Insulin-like growth factor-binding protein 7

Also known as: FSTL2, IBP7_HUMAN, IGFBP-7, MAC25, PSF

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q16270
Gene
IGFBP7
Ensembl
ENSG00000163453
Chromosome
4
Canonical length
282 aa
Protein class
Disease related genes, Plasma proteins, Predicted secreted proteins
Subcellular location
Golgi apparatus
Secretome location
Secreted to blood

OverviewNCBI Gene

This gene encodes a member of the insulin-like growth factor (IGF)-binding protein (IGFBP) family. IGFBPs bind IGFs with high affinity, and regulate IGF availability in body fluids and tissues and modulate IGF binding to its receptors. This protein binds IGF-I and IGF-II with relatively low affinity, and belongs to a subfamily of low-affinity IGFBPs. It also stimulates prostacyclin production and cell adhesion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene, and one variant has been associated with retinal arterial macroaneurysm (PMID:21835307). [provided by RefSeq, Dec 2011]

Canonical amino-acid sequenceUniProt

282 residues, UniProt reviewed canonical sequence.

>Q16270|IGFBP7
     1  MERPSLRALL LGAAGLLLLL LPLSSSSSSD TCGPCEPASC PPLPPLGCLL GETRDACGCC
    61  PMCARGEGEP CGGGGAGRGY CAPGMECVKS RKRRKGKAGA AAGGPGVSGV CVCKSRYPVC
   121  GSDGTTYPSG CQLRAASQRA ESRGEKAITQ VSKGTCEQGP SIVTPPKDIW NVTGAQVYLS
   181  CEVIGIPTPV LIWNKVKRGH YGVQRTELLP GDRDNLAIQT RGGPEKHEVT GWVLVSPLSK
   241  EDAGEYECHA SNSQGQASAS AKITVVDALH EIPVKKGEGA EL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IGFBP7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.41
Highest tissue expression
4,198 nTPM

Expression across tissuesHPA

Tissue

  • blood vessel: 4,198 nTPM
  • choroid plexus: 1,635 nTPM
  • kidney: 1,206 nTPM
  • heart muscle: 1,075 nTPM
  • thyroid gland: 958 nTPM
  • adipose tissue: 791 nTPM

Single-cell type

  • peritubular myoid cells: 11,372 nCPM
  • leydig cells: 8,234 nCPM
  • hepatic stellate cells: 7,539 nCPM
  • pericytes: 5,056 nCPM
  • vascular smooth muscle cells: 4,157 nCPM
  • decidual stromal cells: 3,076 nCPM

Immune cell

  • eosinophil: 22 nTPM
  • NK-cell: 11 nTPM
  • myeloid DC: 11 nTPM
  • non-classical monocyte: 4.5 nTPM
  • intermediate monocyte: 4.1 nTPM
  • classical monocyte: 3.9 nTPM

Brain region

  • choroid plexus: 2,655 nTPM
  • thalamus: 327 nTPM
  • medulla oblongata: 313 nTPM
  • hypothalamus: 219 nTPM
  • pons: 218 nTPM
  • midbrain: 210 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IGFBP7.

Disease | AllUniProt

Conditions IGFBP7 is implicated in, by any mechanism.

Disease | GeneticClinVar

2 pathogenic / likely-pathogenic of 55 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.12
gnomAD pLI
0
gnomAD missense Z
0.31
DepMap mean gene effect
-0.1
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IGFBP7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IGFBP7 as an antibody target. Whether an autoantibody or antibody against IGFBP7 could matter depends on whether native IGFBP7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IGFBP7 is annotated as secreted, so native IGFBP7 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label IGFBP7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IGFBP7. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...